Association of Stress-Related Disorders

Association of Stress-Related Disorders

Original Investigation | March 9, 2020

Key Points

Question  Do severe psychiatric reactions induced by trauma or other life stressors increase the risk for neurodegenerative diseases?

Findings  In a nationwide cohort study of individuals with stress-related disorders and those without such disorders, the exposed individuals were at a considerably higher risk of developing neurodegenerative diseases compared with their matched unexposed counterparts. This risk elevation was more pronounced for vascular neurodegenerative diseases (risk increase of 80%) than for primary neurodegenerative diseases (risk increase of 31%).

Meaning  These findings suggest that stress-related disorders may be associated with the subsequent risk of neurodegenerative diseases, possibly through a cerebrovascular pathway.

Abstract

Importance  Posttraumatic stress disorder (PTSD) has been associated with increased risk for dementia. Less is known, however, about other stress-related disorders and their associations with neurodegenerative diseases.

Objective  To examine the association between stress-related disorders and risk for neurodegenerative diseases.

Design, Setting, and Participants  This population-matched and sibling cohort study was conducted in Sweden using data from nationwide health registers, including the Swedish National Patient Register. Individuals who received their first diagnosis of stress-related disorders between January 1, 1987, and December 31, 2008, were identified. Individuals who had a history of neurodegenerative diseases, had conflicting or missing information, had no data on family links, or were aged 40 years or younger at the end of the study were excluded. Individuals with stress-related disorders were compared with the general population in a matched cohort design; they were also compared with their siblings in a sibling cohort. Follow-up commenced from the age of 40 years or 5 years after the diagnosis of stress-related disorders, whichever came later, until the first diagnosis of a neurodegenerative disease, death, emigration, or the end of follow-up (December 31, 2013), whichever occurred first. Data analyses were performed from November 2018 to April 2019.

Exposures  Diagnosis of stress-related disorders (PTSD, acute stress reaction, adjustment disorder, and other stress reactions).

Main Outcomes and Measurements Neurodegenerative diseases were identified through the National Patient Register and classified as primary or vascular. Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis were evaluated separately. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) with 95% CIs after controlling for multiple confounders.

Results  The population-matched cohort included 61 748 exposed individuals and 595 335 matched unexposed individuals. A total of 44 839 exposed individuals and their 78 482 unaffected full siblings were included in the sibling cohort analysis. The median (interquartile range) age at the start of follow-up was 47 (41-56) years, and 24 323 (39.4%) of the exposed individuals were male. The median (interquartile range) follow-up was 4.7 (2.1-9.8) years. Compared with unexposed individuals, individuals with a stress-related disorder were at an increased risk of neurodegenerative diseases (HR, 1.57; 95% CI, 1.43-1.73). The risk increase was greater for vascular neurodegenerative diseases (HR, 1.80; 95% CI, 1.40-2.31) than for primary neurodegenerative diseases (HR, 1.31; 95% CI, 1.15-1.48). A statistically significant association was found for Alzheimer disease (HR, 1.36; 95% CI, 1.12-1.67) but not Parkinson disease (HR, 1.20; 95% CI, 0.98-1.47) or amyotrophic lateral sclerosis (HR, 1.20; 95% CI, 0.74-1.96). Results from the sibling cohort corroborated results from the population-matched cohort.

Conclusions and Relevance  This study showed an association between stress-related disorders and an increased risk of neurodegenerative diseases. The relative strength of this association for vascular neurodegenerative diseases suggests a potential cerebrovascular pathway.

 

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • The Shift in Roles: Caring for Our Parents

    The Shift in Roles: Caring for Our Parents

    Laura Louizos

    As our parents age, especially when they face health challenges, we often find ourselves stepping into roles we never imagined. It's a profound shift – from being the child to...

    The Shift in Roles: Caring for Our Parents

    Laura Louizos

    As our parents age, especially when they face health challenges, we often find ourselves stepping into roles we never imagined. It's a profound shift – from being the child to...

  • Understanding the Four Stages of Multiple System Atrophy (MSA) with Detailed Symptom Description

    Understanding the Four Stages of Multiple Syste...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that impacts movement, balance, and autonomic functions. Here's a closer look at the symptoms across its four stages: Stage 1:...

    Understanding the Four Stages of Multiple Syste...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that impacts movement, balance, and autonomic functions. Here's a closer look at the symptoms across its four stages: Stage 1:...

  • The Power of Shared Experiences in Navigating Atypical Parkinsonism

    The Power of Shared Experiences in Navigating A...

    Laura Louizos

    When facing the challenges of atypical Parkinsonism, including conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Corticobasal Degeneration (CBD), the journey can feel isolating and overwhelming. However,...

    The Power of Shared Experiences in Navigating A...

    Laura Louizos

    When facing the challenges of atypical Parkinsonism, including conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Corticobasal Degeneration (CBD), the journey can feel isolating and overwhelming. However,...

  • Misdiagnosed: When Parkinson's Isn't Parkinson's

    Misdiagnosed: When Parkinson's Isn't Parkinson's

    Laura Louizos

    The journey to a Parkinson's disease (PD) diagnosis can be fraught with uncertainties, especially when the symptoms mimic those of other neurodegenerative disorders. Atypical parkinsonism, often referred to as "Parkinson's...

    Misdiagnosed: When Parkinson's Isn't Parkinson's

    Laura Louizos

    The journey to a Parkinson's disease (PD) diagnosis can be fraught with uncertainties, especially when the symptoms mimic those of other neurodegenerative disorders. Atypical parkinsonism, often referred to as "Parkinson's...

1 of 4